Melissa Vo is researching the development of scene processing/The cognitive psychologist has come from the Harvard Medical School to Frankfurt.
FRANKFURT. Anyone who has ever looked for milk in somebody else's house knows that they have to go into the kitchen, open the refrigerator and look in the compartment in the fridge door. Even little children know which objects to find where within a room. Cognitive Psychologist Melissa Vo concerns herself with the question of how this scene processing ability develops. The 33-year old professor for Cognitive Psychology was recently appointed to Goethe University from Harvard Medical School. In addition, as a grant recipient of the German Research Foundation’s Emmy Noether Program, she has established the "Scene Grammar Lab" at the Psychology Institute.
"Most people take the ease with which they orient themselves in their environment, perceive and interact with objects, for granted." says Melissa Vo. She first learnt that this is by no means the case when pursuing her dissertation at the Ludwig Maximilian University in Munich, where she worked, among others, with physicists and engineers on artificial intelligence for technical systems. "While a child can find their favourite stuffed animal under a blanket without any difficulty, this presents an almost insurmountable challenge to a robot or a computer vision algorithm," she says.
While natural scenes are complex, their structure follows certain regularities that the human brain clearly learns very early. Perception is therefore greatly impacted by the knowledge of the arrangement of objects in space. For instance, most objects lie on a horizontal plane. For this reason, if experimental subjects are shown images of floating objects, the resulting irritation is expressed in altered brain signals. "The EEG then shows responses similar to when subjects hear or read a grammatically incorrect sentence," says Vo. Similarly, she was able to determine marked deviations in gaze patterns with the help of eye-tracking systems.
These observations suggest that scene processing might rely on mechanisms similar to knowledge about grammatical structures in language or even music. Melissa Vo hopes, therefore, to develop diagnostic tools for the early recognition of children who suffer from reading and writing difficulties, for example, by testing their implicit scene processing abilities before they enter formal schooling. Moreover, her work is also significant for the development of technical assistance systems that could, for example, be intended to support the elderly at home. Together with her 3 doctoral candidates, she is currently setting up a perception laboratory in Frankfurt. The experimental subjects will not only be tested in front of computer screens, as previously, but will also have to search actively for objects and interact with them in real-world scenarios using mobile eye-tracking glasses.
The Munich born and bred researcher is the daughter of a Vietnamese father and American mother. Frankfurt is an interesting research location for her because of the many co-operation partners in town, e.g. at the Institute of Psychology, the Frankfurt Institute for Advanced Studies (FIAS), or the Ernst Strüngmann Institute (ESI) for Neuroscience in Cooperation with the Max Planck Society. She has other partners at the Universities of Darmstadt, Gießen and Marburg. Vo, who has worked in the USA for the past 5 years, also has established an extensive network of contacts at American Universities, which her students can benefit from. "When I was still doing my undergraduate work, my Professor arranged a research internship for me at the Columbia University in New York City. In my opinion, the experiences from that time were extremely formative and gave me more perspective," says the researcher. Together with her American colleagues, she has also organized the international OPAM conference (on Object Perception, Attention, and Memory) to promote young scientists in the field of Cognitive Psychology.
Information: Prof. Dr. Melissa Vo, Cognitive Psychology I, Campus Westend, Tel.: (069) 798 35342, firstname.lastname@example.org.
5-LO inhibitors eliminate cells in culture and mouse models
FRANKFURT. Despite improved therapy, only one out of every two adult patients survive acute myeloid leukaemia (AML). The mean survival time for this disease, which predominantly occurs in the elderly, is less than a year for patients over 65 years. It is assumed that leukaemic stem cells, which cannot be completely eliminated during treatment, are the origin of relapse. However, as has been discovered by a team of Frankfurt-based researchers, these cells do have a weakness: In the current edition of the high impact journal "Cancer Research", they report that the enzyme 5-lipoxygenase (5-LO) plays a significant role in the survival of leukaemic AML stem cells.
5-LO is known for its role in inflammatory diseases like asthma. A team led by Dr. Marin Ruthardt from the Haematology Department of the Medical Clinic II and Dr. Jessica Roos, Prof. Diester Steinhilber and Prof. Thorsten Jürgen Maier from the Institute for Pharmaceutical Chemistry showed that the leukaemic stem cells in a subgroup of AML could be selectively and efficiently attacked by 5-LO inhibitors. This was demonstrable in cell culture models as well as in leukaemia mouse models.
"These results provide the basis for the potential implementation of 5-LO-inhibitors as stem cell therapeutic agents for a sustained AML cure, although this must be investigated further in preclinical and clinical studies in humans," explains Dr. Ruthardt. "In addition, there are plans for further molecular biological studies with the objective of understanding exactly how the 5-LO inhibitors act on the leukaemic cells." Prof. Maier continued.
Roos et al.: 5-lipoxygenase is a candidate target for therapeutic management of stem cell-like cells in acute myeloid leukemia, in Cancer Research Volume (2014), Published OnlineFirst July 31, 2014;
Information PD Dr. Martin Ruthardt, Haematology/Medical Clinic II, Tel. +49/ 69/6301–5338, email: email@example.com or Prof. Dr. Thorsten Jürgen Maier, Institute for Pharmaceutical Chemistry, Riedberg Campus, Tel.: +49/69/7982-934, email: firstname.lastname@example.org.